Navigation Links
Tumor Resistant Mice Point To Novel Cancer Treatments

Researchers have established that white blood cells, derived from immune mice, have an innate immunity against cancer, which can be exploited// in the development of novel forms of cancer treatment. When such cells were introduced into other mice with cancer, it was found to confer a lifelong immunity against the much-dreaded disease.

This study for the first time highlights the presence of a biological pathway in a specific species. Previous studies had suggested a similar link in humans as well, that could be harnessed to arrive at a novel approach for cancer treatment.

‘The idea of cells being able to kill tumor cells ... is very exciting. But this is a mouse, and there is no guarantee that the same gene will exist in people,’ said biologist Howard Young of the National Cancer Institute's Center for Cancer Research.

’This is a truly remarkable phenomenon ... and it really needs confirmation from other institutions," said Dr. Zhen Cui of Wake Forest. The limited availability of these special mice ensures that the above results have not been reported by any another lab or research organisation. The results of this interesting study have been published in the Proceedings of the National Academy of Science.

The researchers are said to have ended up with the remarkable immune mice by accident, in the year 1999. The researchers initial studies were targeted at identifying biological mechanisms behind the spread of cancer.

As a part of this study, highly virulent cancer cells were introduced into mice. Surprisingly, one of the mice injected with cancer cells had not developed any tumor. This effect was seen even when the animal was injected with tumor cells, approximating to 10% of its body weight.

Out of curiosity, the researchers bread the mouse, only to find that 50% of its offspring had the same kind of tumor resistance. Cross breeding experiments were also taken up. The researchers upon analysis found that white blood cells of the tumor resistant mice induced a killing process called cytolysis. A combination of WBCs (neutrophils, macrophages and natural killer cells) from the special mice was then injected into mice with tumors.

As expected, these injected cells were found to destroy the tumor, even the most aggressive forms. More importantly the healthy tissue was unaffected and normal mice with tumors developed a life long immunity against tumors.

‘This is the first report of a novel [treatment] mechanism. The two most dramatic things are: one, that the response itself is outstanding, and two, the fact that they looked at a variety of different cell lines and found the activity was there for all of them, said Dr. Andrew Raubitschek, a cancer immunologist at the City of Hope National Medical Center in Duarte.

‘This deserves intensive follow-up. Cui's papers are technically sound, carefully controlled and well thought out. But whenever there is a result this surprising, it's always important to have others confirm it,’ concluded Dr. Richard Miller of the University of Michigan Medical School.
br>
'"/>




Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Radiofrequency Energy Cooks Tumors Without Surgery
3. New Liver Tumor Treatment
4. Latest Tumor Classification More Informative
5. New Technique For Benign Breast Tumors
6. Another Treatment Option for Benign Tumors
7. Understanding The Origin Of Tumors
8. Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors
9. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
10. Lipoma Arborescens: A Rare Tumor Of The Knee
11. Researchers Develop Mouse Model Of Brain Tumor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... ... of the GlycoMark test throughout the Northeast U.S. , GlycoMark is the ... diabetes. The GlycoMark test provides a clinically proven one- to two-week measure of ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a leading ... Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, a ... of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and Vitamin ...
(Date:4/27/2017)... and DENVER (PRWEB) , ... April 27, 2017 ... ... Health, the nation’s leading respiratory hospital, based in Denver, Colorado, announced an agreement ... is enabled by the continuing support of the Jane and Leonard Korman Family ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, ... focused on providing the Urology, Uro/Gyn and Gynecology ... that Ash Keswani has joined the Company as ... this newly created position, Mr. Keswani will report ... CEO. "Our organization is delighted that ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
Breaking Medicine Technology: